State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development Venkata YellepeddiJoseph RowerCatherine M. T. Sherwin Review Article 18 May 2018 Pages: 1 - 13
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis Sophie E. BerendsAnne S. StrikRon A. A. Mathôt Review Article Open access 12 May 2018 Pages: 15 - 37
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance Eva GermovsekCharlotte I. S. BarkerJoseph F. Standing Review Article Open access 19 April 2018 Pages: 39 - 52
Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children Sophida BoonsathornIek ChengJoseph F. Standing Original Research Article Open access 20 April 2018 Pages: 53 - 61
Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials Rasmus Vestergaard JuulMichael Højby RasmussenRune Viig Overgaard Original Research Article Open access 18 April 2018 Pages: 63 - 75
Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia Robert A. HauserRajesh PahwaGregory T. Went Original Research Article Open access 18 May 2018 Pages: 77 - 88
Choosing the Allometric Exponent in Covariate Model Building Jaydeep SinhaHesham S. Al-SallamiStephen B. Duffull Original Research Article 27 April 2018 Pages: 89 - 100
Population Pharmacokinetic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using a Michaelis–Menten Approximation of a Target-Mediated Drug Disposition Model—Support for a Biologics License Application Submission: Part I Jean-Marie MartinezAurélie BrunetDavid Fabre Original Research Article Open access 03 May 2018 Pages: 101 - 113
Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II Xavier NicolasNassim DjebliDavid Fabre Original Research Article Open access 03 May 2018 Pages: 115 - 130
The Influence of Normalization Weight in Population Pharmacokinetic Covariate Models Sebastiaan C. GouloozeSwantje VöllerCatherijne A. J. Knibbe short communication Open access 23 March 2018 Pages: 131 - 138
Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance Eva GermovsekCharlotte I. S. BarkerJoseph F. Standing Correction Open access 17 December 2018 Pages: 139 - 139
Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children Sophida BoonsathornIek ChengJoseph F. Standing Correction Open access 17 December 2018 Pages: 141 - 141